Adela

FOSTER CITY, CA · Founded 2020 · CIK 0001852167 · Medtech · Private

Genome-wide methylation analysis platform for early cancer detection from blood samples

adelabio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$93M
6 Form D · Apr 2026
5 months since last filing
Contracts
—
No federal contracts on record
Patents
23
0 granted · 23 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$29,999,988
Private capital raisedForm D · SEC$28,031,993
Private capital raised· 1 of 2 same dayForm D · SEC$3,296,554
Private capital raised· 2 of 2 same dayForm D · SEC$1,187,700
Private capital raisedForm D · SEC$25,425,442
Private capital raisedForm D · SEC$5,000,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1191METABOLITEDX CORP——
1192AION Prosthetics Corp.—$100K
1193Nueon Inc.—$325K
1194Adela—$93M
1195MARS Bioimaging Ltd—$2.0M
1196Medluidics LLC——
1197PathSpot Technologies, Inc.—$3.7M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 18 related persons
  • Lisa AldersonDirector · Executive Officer
  • David BonitaDirector
  • Scott BratmanDirector · Executive Officer · Promoter
  • Paul BrownDirector
  • Daniel De CarvalhoExecutive Officer
  • Daniel Diniz De CarvalhoExecutive Officer · Promoter
  • Andrew ElBardissiDirector
  • Anne-Renee HartmanExecutive Officer
  • Anne-Renee Hartman FeldmanExecutive Officer
  • Priscilla HuangExecutive Officer
  • Maneesh JainDirector · Promoter
  • Karla JarvisExecutive Officer
  • Abraham KometzDirector
  • Lindsay MateoExecutive Officer
  • Christopher ParkerExecutive Officer
  • David ScheerDirector · Executive Officer · Promoter
  • Robert WeisskoffDirector
  • Alan WilliamsExecutive Officer

Patents

USPTO · 0 granted of 23
  • Methods And Systems For Cell-free Nucleic Acid Processingapplication
  • Methods And Systems For Cell-free Nucleic Acid Processingapplication
  • Methods And Systems For Generating Sequencing Librariesapplication
  • Methods And Systems For Cell-free Nucleic Acid Processingapplication
  • Methods And Systems For Cell-free Nucleic Acid Processingapplication
  • Methods And Systems For Generating Sequencing Librariesapplication
  • Methods And Systems For Tissue Informed Differentially Methylated Region Analysisapplication
  • Methods And Systems For Cell-free Nucleic Acid Processingapplication
  • Methods And Systems For Cell-free Nucleic Acid Processingapplication
  • Methods And Systems For Generating Sequencing Librariesapplication
  • Methods And Systems For Cell-free Nucleic Acid Processingapplication
  • Methods And Systems For Cell-free Nucleic Acid Processingapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.